Insight Molecular Diagnostics Inc. Advertising Expense
Insight Molecular Diagnostics Inc. (IMDX) reported Advertising Expense of $263.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. advertising expense for the quarter ending 2026-06-30 was $263.00K, a 58.43% increase year-over-year.
- Insight Molecular Diagnostics Inc. advertising expense for the quarter ending 2026-03-31 was $135.00K, a 48.35% increase year-over-year.
- Insight Molecular Diagnostics Inc. advertising expense for the quarter ending 2025-12-31 was $235.00K, a 74.07% increase year-over-year.
- Insight Molecular Diagnostics Inc. advertising expense for the quarter ending 2025-09-30 was $98.00K, a 145.00% increase year-over-year.
- Insight Molecular Diagnostics Inc. advertising expense for fiscal 2025 was $590.00K, a 128.68% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. advertising expense for fiscal 2024 was $258.00K, a 35.79% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. advertising expense for fiscal 2023 was $190.00K.
| Period end | Advertising Expense 3 month | Advertising Expense 6 month | Advertising Expense 9 month | Advertising Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $263.00K 10-Q · filed 2026-08-10 | $398.00K 10-Q · filed 2026-08-10 | $633.00K derived: sum of 3 quarters · filed 2026-08-10 | $731.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $135.00K 10-Q · filed 2026-05-13 | $370.00K derived: sum of 2 quarters · filed 2026-05-13 | $468.00K derived: sum of 3 quarters · filed 2026-05-13 | $634.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $333.00K derived: sum of 2 quarters · filed 2026-03-26 | $499.00K derived: sum of 3 quarters · filed 2026-08-10 | $590.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $98.00K 10-Q · filed 2025-11-10 | $264.00K derived: sum of 2 quarters · filed 2026-08-10 | $355.00K 10-Q · filed 2025-11-10 | $490.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $166.00K 10-Q · filed 2026-08-10 | $257.00K 10-Q · filed 2026-08-10 | $392.00K derived: sum of 3 quarters · filed 2026-08-10 | $432.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $91.00K 10-Q · filed 2026-05-13 | $226.00K derived: sum of 2 quarters · filed 2026-05-13 | $266.00K derived: sum of 3 quarters · filed 2026-05-13 | $310.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $175.00K derived: sum of 2 quarters · filed 2026-03-26 | $219.00K derived: sum of 3 quarters · filed 2026-03-26 | $258.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $40.00K 10-Q · filed 2025-11-10 | $84.00K derived: sum of 2 quarters · filed 2025-11-10 | $123.00K 10-Q · filed 2025-11-10 | $188.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $44.00K 10-Q · filed 2025-08-11 | $83.00K 10-Q · filed 2025-08-11 | $148.00K derived: sum of 3 quarters · filed 2025-08-11 | $194.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $39.00K 10-Q · filed 2025-05-12 | $104.00K derived: sum of 2 quarters · filed 2025-05-12 | $150.00K derived: sum of 3 quarters · filed 2025-05-12 | $193.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $111.00K derived: sum of 2 quarters · filed 2025-03-24 | $154.00K derived: sum of 3 quarters · filed 2025-03-24 | $190.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $46.00K 10-Q · filed 2024-11-12 | $89.00K derived: sum of 2 quarters · filed 2024-11-12 | $125.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $43.00K 10-Q · filed 2024-08-08 | $79.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |